{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:37:24Z","timestamp":1784043444609,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.vaccine.2011.01.053","type":"journal-article","created":{"date-parts":[[2011,2,4]],"date-time":"2011-02-04T09:15:33Z","timestamp":1296810933000},"page":"2679-2681","source":"Crossref","is-referenced-by-count":14,"title":["Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis"],"prefix":"10.1016","volume":"29","author":[{"given":"Ling-yun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo-dan","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-jie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-bo","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.01.053_bib0005","first-page":"362","article-title":"Rabies prevention and control, safety of vaccines and anti-serum","volume":"7","author":"Dong","year":"2006","journal-title":"Chin J Prev Med"},{"key":"10.1016\/j.vaccine.2011.01.053_bib0010","series-title":"Vaccines","author":"Stanley","year":"2008"},{"key":"10.1016\/j.vaccine.2011.01.053_bib0015","series-title":"Laboratory techniques in rabies","author":"Meslin","year":"1996"},{"issue":"14","key":"10.1016\/j.vaccine.2011.01.053_bib0020","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/0264-410X(93)90167-V","article-title":"Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cells rabies vaccine: a nation-wide prospective study","volume":"11","author":"Fisbein","year":"1993","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.01.053_bib0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0264-410X(94)90308-5","article-title":"A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis","volume":"12","author":"Suntharasamai","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.053_bib0030","article-title":"WHO expert consultation on rabies: first report","volume":"vol. 931","year":"2004"},{"key":"10.1016\/j.vaccine.2011.01.053_bib0035","series-title":"Laboratory techniques in rabies","first-page":"181","article-title":"Rapid fluorescent focus inhibition test for determining rabies virus-neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.vaccine.2011.01.053_bib0040","volume":"vol. 82","year":"2007"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2011.01.053_bib0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1708-8305.1999.tb00525.x","article-title":"Economic issues in post-exposure rabies treatment","volume":"6","author":"Wilde","year":"1999","journal-title":"J Travel Med"},{"issue":"23 November (48)","key":"10.1016\/j.vaccine.2011.01.053_bib0050","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1016\/j.vaccine.2007.09.043","article-title":"Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium","volume":"25","author":"Costa","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.01.053_bib0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1708-8305.1999.tb00525.x","article-title":"Economic issues in post-exposure rabies treatment","volume":"6","author":"Wilde","year":"1999","journal-title":"J Travel Med"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.01.053_bib0060","first-page":"1115","article-title":"Vaccination reactions and immunogenicity of Chinese-made freeze-dried human-use rabies vaccine (Vero cell)","volume":"21","author":"Wang","year":"2008","journal-title":"Chin J Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T10:06:55Z","timestamp":1559988415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":12,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0264410X11001046"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.01.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}